GB Sciences (OTCMKTS:GBLX) Stock Passes Above Fifty Day Moving Average – Should You Sell?

GB Sciences, Inc. (OTCMKTS:GBLX) crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $0.00 and traded as high as $0.0003. GB Sciences shares last traded at $0.0003, with a volume of 1,350 shares changing hands.

GB Sciences Stock Down 25.0%

GB Sciences Company Profile

GB Sciences, Inc is a biotechnology company focused on the research, development and commercialization of cannabinoid-based medicines. Leveraging both botanical and synthetic approaches, the company aims to create novel therapies targeting oncology, neurology and inflammatory diseases. Through its proprietary drug discovery platform, GB Sciences seeks to identify and advance lead compounds that harness the therapeutic potential of cannabinoids while ensuring high standards of quality and safety.

The company operates a cGMP-compliant research and manufacturing facility in Irvine, California, and maintains partnerships to support cultivation and extraction activities in select geographies.